Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Extrawell Pharmaceutical Holdings Limited Proxy Solicitation & Information Statement 2004

Sep 6, 2004

49517_rns_2004-09-06_b847b838-ec2c-48f7-a6aa-6dddfdbf4e30.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [54 x 63] intentionally omitted <==

EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED

*

(incorporated in Bermuda with limited liability)

(Stock code: 858)

PROXY FORM

Form of proxy for use by shareholders at the annual general meeting to be convened at 2:00 p.m. on Thursday, 14 October 2004. I/We (note a)

of

being the holder(s) of (note b) shares of HK$0.01 each of EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED (the “Company”) hereby appoint the Chairman of the Meeting or

of

to act as my/our proxy (note c) at the Annual General Meeting of the Company to be held at Gloucester Room 1, 3rd Floor, The Excelsior, 281 Gloucester Road, Causeway Bay, Hong Kong on Thursday, 14 October 2004 at 2:00 p.m. and at any adjournment thereof and to vote on my/our behalf as directed below, or, if no such indication is given, as my/ our proxy thinks fit.

Please make a mark in the appropriate boxes to indicate how you wish your vote(s) to be cast on a poll (note d) .

RESOLUTIONS FOR AGAINST
1. To receive and approve the audited consolidated financial statements and the
reports of the directors and auditors for the year ended 31 March 2004
2. (a)
To re-elect Dr. Xie Yi as executive director
2. (b)
To re-elect Mr. Fang Lin Hu as independent non-executive director
2. (c)
To authorise the board of directors to fix the directors’ remuneration
3. To appoint the Company’s auditors and authorise the board of directors to fix
their remuneration
4. To approve the proposed alterations to the Company’s Bye-Laws
5. To grant a general mandate to the directors of the Company to allot, issue and
otherwise deal with the Company’s shares
6. To grant a general mandate to the directors of the Company to purchase the
Company’s shares
7. To add the nominal amount of the shares repurchased by the Company to the
mandate granted to the directors under resolution no. 5

Dated the day of 2004 Shareholder’s signature (notes e, f, g and h)

Notes:

  • (a) Full name(s) and address(es) are to be inserted in BLOCK CAPITALS. The name of all joint holders should be stated.

  • (b) Please insert the number of shares registered in your name(s). If no number is inserted, this form of proxy will be deemed to relate to all the shares in the capital of the Company registered in your name(s).

  • (c) A proxy need not be a member of the Company. If you wish to appoint some person other than the Chairman of the Meeting as your proxy, please delete the words “the Chairman of the Meeting or” and insert the name and address of the person appointed proxy in the space provided.

  • (d) If you wish to vote for any of the resolutions set out above, please tick (“�”) the boxes marked “For”. If you wish to vote against any resolutions, please tick (“�”) the boxes marked “Against”. If this form returned is duly signed but without specific direction on any of the proposed resolutions, the proxy will vote or abstain at his discretion in respect of all resolutions; or if in respect of a particular proposed resolution there is no specific direction, the proxy will, in relation to that particular proposed resolution, vote or abstain at his discretion. A proxy will also be entitled to vote at his discretion on any resolution properly put to the meeting other than those set out in the notice convening the meeting or any adjourned meeting.

  • (e) In the case of joint holders this form of proxy may be signed by any joint holder, but if more than one joint holder is present at the meeting, whether in person or by proxy, that one of the joint holders whose name stands first on the register of members in respect of the relevant joint holding shall alone be entitled to vote in respect thereof.

  • (f) The form of proxy must be signed by a shareholder, or his attorney duly authorised in writing, or if the shareholder is a corporation, either under its Common Seal or under the hand of an officer or attorney so authorised.

  • (g) To be valid, this form of proxy together with any power of attorney or other authority (if any) under which it is signed or a notarially certified copy of such power or authority must be deposited at the office(s) of the Company’s Hong Kong branch share registrar, Tengis Limited, Ground Floor, Bank of East Asia Harbour View Centre, 56 Gloucester Road, Wanchai, Hong Kong not later than 48 hours before the time of the meeting or any adjourned meeting.

  • (h) Any alteration made to this form should be initialled by the person who signs the form.

  • For identification purposes only.